Cyclo-oxygenase-2 (COX-2) inhibition reduces apoptosis in acute myocardial infarction

被引:0
|
作者
A. Abbate
F. Limana
M. C. Capogrossi
D. Santini
G. G. L. Biondi-Zoccai
S. Scarpa
A. Germani
S. Straino
A. Severino
F. Vasaturo
M. Campioni
G. Liuzzo
F. Crea
G. W. Vetrovec
L. M. Biasucci
A. Baldi
机构
[1] Virginia Commonwealth University,Department of Medicine
[2] Catholic University,Institute of Cardiology
[3] Istituto Dermopatico Immacolata,Department of Vascular Pathology
[4] Campus Bio-Medico University,Section of Oncology
[5] Università degli Studi “La Sapienza”,Department of Experimental Medicine and of Pathology
[6] Centro Cardiologico Fondazione Monzino,Department of Biochemistry and Biophysics “F. Cedrangolo”, Section of Pathologic Anatomy
[7] Second University of Naples,Department of Medicine
[8] Virginia Commonwealth University,undefined
来源
Apoptosis | 2006年 / 11卷
关键词
apoptosis; COX2-inhibitors; cyclo-oxygenase; myocardial infarction; remodelling;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1061 / 1063
页数:2
相关论文
共 50 条
  • [1] Cyclo-oxygenase-2 (COX-2) inhibition reduces apoptosis in acute myocardial infarction
    Abbate, A.
    Limana, F.
    Capogrossi, M. C.
    Santini, D.
    Biondi-Zoccai, G. G. L.
    Scarpa, S.
    Germani, A.
    Straino, S.
    Severino, A.
    Vasaturo, F.
    Campioni, M.
    Liuzzo, G.
    Crea, F.
    Vetrovec, G. W.
    Biasucci, L. M.
    Baldi, A.
    APOPTOSIS, 2006, 11 (06) : 1061 - 1063
  • [2] Cyclo-oxygenase-2 (COX-2) expression at the site of recent myocardial infarction: friend or foe?
    Abbate, A
    Santini, D
    Biondi-Zoccai, GGL
    Scarpa, S
    Vasaturo, F
    Liuzzo, G
    Bussani, R
    Silvestri, F
    Baldi, F
    Crea, F
    Biasucci, LM
    Baldi, A
    HEART, 2004, 90 (04) : 440 - 443
  • [3] Arcoxia, NSAIDs selective inhibitor of cyclo-oxygenase-2 (COX-2)
    Buxeraud, Jacques
    ACTUALITES PHARMACEUTIQUES, 2010, 49 (498): : 9 - 10
  • [4] Human visceral pain hypersensitvity is independent of cyclo-oxygenase-2 (COX-2)
    Willert, R
    Delaney, C
    Hobson, A
    Thompson, D
    Aziz, Q
    GASTROENTEROLOGY, 2004, 126 (04) : A644 - A644
  • [5] ROLE OF CYCLO-OXYGENASE-2 (COX-2) IN CARCINOGENESIS AND TUMOR PROGRESSION IN HEPATOCELLULAR CARCINOMA
    Sakhuja, P.
    Rooge, S. B.
    Hissar, S. S.
    Singh, A.
    Gondal, R.
    Sarin, S. K.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S293 - S293
  • [6] Expression of cyclo-oxygenase (COX-2) and Bax protein in acute myocardial infraction
    Tsipis, A.
    Athanassiadou, A.
    Athanassiadou, P.
    Kavantzas, N.
    Agrogiannis, G.
    Patsouris, E.
    HISTOPATHOLOGY, 2008, 53 : 81 - 81
  • [7] Cyclo-oxygenase-2 (COX-2) mRNA expression and hormone receptor status in breast cancer
    McCarthy, K.
    Bustin, S. A.
    Ogunkolade, B.
    Khalaf, S.
    Laban, C. A.
    McVittie, C. J.
    Carpenter, R.
    Jenkins, P. J.
    EJSO, 2006, 32 (07): : 707 - 709
  • [8] Use of the cyclo-oxygenase-2 (COX-2) inhibitor DFU in experimental glaucoma surgery.
    Lesk, MR
    Ponomarenko, S
    Beaudoln, N
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S81 - S81
  • [9] Inhibition of cyclo-oxygenase-2 exacerbates ischaemia-induced acute myocardial dysfunction in the rabbit
    Rossoni, G
    Muscara, MN
    Cirino, G
    Wallace, JL
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (06) : 1540 - 1546
  • [10] Renal effects of cyclo-oxygenase-2 inhibition
    Thomas, MC
    Harris, DCH
    NEPHROLOGY, 2002, 7 (06) : 281 - 286